(Q40212319)

18 September 2017

title

Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts (English)

1 reference

18 September 2017

1 reference

Mitsune Tanimoto

1 reference

18 September 2017

Kozo Masuda

1 reference

18 September 2017

Akio Hiraki

1 reference

18 September 2017

Nobuharu Fujii

1 reference

18 September 2017

Toshiyuki Watanabe

1 reference

18 September 2017

Motoyuki Tanaka

1 reference

18 September 2017

Kosei Matsue

1 reference

18 September 2017

Yoichiro Ogama

1 reference

18 September 2017

Mamoru Ouchida

1 reference

18 September 2017

Kenji Shimizu

1 reference

18 September 2017

Kazuma Ikeda

1 reference

18 September 2017

language of work or name

1 reference

1 January 2007

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

1 reference

18 September 2017

page(s)

102-108

1 reference

Natural history of HLA expression during tumour development.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Microsatellites in the HLA region: 1999 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

Tumor-specific cytotoxic T lymphocyte responses against chondrosarcoma with HLA haplotype loss restricted by the remaining HLA class I allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00356.X

10.1111/J.1349-7006.2006.00356.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference